Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery

NCT ID: NCT00868400

Last Updated: 2015-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

215 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to provide conclusive clinical evidence as to whether or not the preoperative administration of oral carbohydrate-rich solutions is effective on the outcomes of patients undergoing colorectal surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preoperative oral carbohydrate loading is an issue that has been investigated extensively in terms of its fundamental and biochemically apparent effects and potential benefits. Most commonly, proponents of the application advocate that it may be beneficial for improving patient outcomes and for decreasing complication rate by attenuating postoperative insulin resistance. To date, however, no study with a sufficient sample size has been able to demonstrate that it has a marked value in clinical practice. Almost all of the clinical benefits ascribed to the application have been based on subjective well-being, which can also be provided with non specific simple beverages. A study conducted to show whether or not the application has direct influence on patient outcome, therefore, could significantly contribute insights on this topic. The present study was planned to consist of three study arms, namely: 1.Study group, which will be given high-carbohydrate beverage (Nutricia preOp®, Numico, Zoetermeer, The Netherlands) 2. Placebo group, which will be given flavored water, and 3. Control group (surgery after overnight fast). The revised power analysis shows that an accrual of 74 patients in each group would allow detecting a 15% difference in the rate of complications with 80% power at the 5% level of significance (two tailed). We hope we will have recruited at least 220 subjects at the end of a two-year course. Once the data recording is complete, this study will be the largest one ever conducted to investigate this topic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Disorders Colorectal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

High-carbohydrate

Group Type EXPERIMENTAL

commercially available high-carbohydrate beverage

Intervention Type DIETARY_SUPPLEMENT

800 ml before the day of surgery, and additional 400 ml two hours prior to surgery

2

Placebo

Group Type PLACEBO_COMPARATOR

flavored water

Intervention Type DIETARY_SUPPLEMENT

will be given in doses equal to those of high-carbohydrate beverage

3

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

commercially available high-carbohydrate beverage

800 ml before the day of surgery, and additional 400 ml two hours prior to surgery

Intervention Type DIETARY_SUPPLEMENT

flavored water

will be given in doses equal to those of high-carbohydrate beverage

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients undergoing colorectal surgery for malignant or benign diseases

Exclusion Criteria

* diabetes
* disorders that prolongs gastric emptying
* existence of an increased risk for aspiration of gastric content
* anal surgery (haemorrhoidectomy, fistulotomy...etc)
* emergency operations
Minimum Eligible Age

16 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

General Hospital of Nikaia "Saint Panteleimon"

OTHER

Sponsor Role collaborator

University Clinical Centre of Kosova

OTHER

Sponsor Role collaborator

University Hospital, Ghent

OTHER

Sponsor Role collaborator

Szeged University

OTHER

Sponsor Role collaborator

European Society for Surgical Research

OTHER

Sponsor Role collaborator

Gulhane School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Fatih Can

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehmet F Can, Assist Prof

Role: STUDY_DIRECTOR

Gulhane School of Medicine, Department of Surgery

Avdyl Krasniqi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Clinical Centre of Kosova, Department of Surgery

Costas Vagianos, Assoc Prof

Role: PRINCIPAL_INVESTIGATOR

Agios Panteleimon Regional Hospital, Deparment of Surgery

Gokhan Yagci, Assoc Prof

Role: PRINCIPAL_INVESTIGATOR

Gulhane School of Medicine, Department of Surgery

Gyorgy Lazar, Prof

Role: PRINCIPAL_INVESTIGATOR

University of Szeged, Department of Surgery

Wim P Ceelen, MD, PhD, Prof

Role: PRINCIPAL_INVESTIGATOR

Ghent University Hospital, Department of Surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gulhane School of Medicine

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRECALICS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.